Divis Laboratories Ltd
₹10037.50
-26.50 (0.26%)
Fri, 06 Nov 2026, 09:40 pm
Health Technology
Pharmaceuticals: Major
24.5KDivis Laboratories Share Price Live Chart
1 Day
-26.50 (0.26%)
No Result Found
Summary
Market Cap (in Cr)
266424.27
Net Profit (in Cr)
2568
P/B
9.40
Sector P/E
38.06
P/E
61.36
EV/EBITDA
39.79
Debt/Equity (Industry)
0.15
Interest Cover (Industry)
24.89
ROCE (Industry)
14.36
RONW (Industry)
12.13
ROE
16.19
ROCE
21
Debt/Equity
0
EPS (TTM)
112.23
Dividend Yield
0.30
Book Value
631.38
Interest Cover
142.17
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (3.2x coverage).
- Dividends after 3 years are expected to be well covered by earnings (3.1x coverage).
- Dividends per share have been stable in the past 10 years.
- Divi's Laboratories's earnings growth is expected to exceed the India market average.
- Divi's Laboratories's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Divi's Laboratories's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Cash flow for Divi's Laboratories is expected to increase but not above the 50% threshold in 2 years time.
- Divi's Laboratories's earnings are expected to grow by 18.9% yearly, however this is not considered high growth (20% yearly).
- Divi's Laboratories's net income is expected to increase but not above the 50% threshold in 2 years time.
Shareholding
| Shareholders | SEPT 2026 | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 |
|---|---|---|---|---|---|
| Promoters | 51.88 | 51.88 | 51.88 | 51.88 | 51.89 |
| FII | 20.38 | 20.20 | 20.29 | 20.08 | 19.39 |
| DII | 19.17 | 19.38 | 19.22 | 19.28 | 19.76 |
| Public | 8.58 | 8.54 | 8.60 | 8.76 | 8.96 |
| Government | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 11616.67 | 10548.67 | 10164.33 | 9480.67 | 9096.33 | 8412.67 | 7344.67 |
| Fibonacci | 10548.67 | 10140.69 | 9888.64 | 9480.67 | 9072.69 | 8820.64 | 8412.67 |
| Camarilla | 10073.70 | 9975.80 | 9877.90 | 9480.67 | 9682.10 | 9584.20 | 9486.30 |
Pivots Level: Classic
R3
+2136
11616.67
R2
+1068
10548.67
R1
+683.67
10164.33
S1
-384.33
9096.33
S2
-1068
8412.67
S3
-2136
7344.67
Moving Average
Period
Value
10-EMA
9873.14
20-EMA
9649.37
30-EMA
9517.27
50-EMA
9262.03
100-EMA
8645.84
200-EMA
7864.90
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 07 Nov 2026 | board-meetings | Quarterly Results, Half Yearly Results | |
| 23 May 2026 | agm | ||
| 23 May 2026 | board-meetings | Accounts, Quarterly Results, Dividend | |
| 23 May 2026 | dividend | ₹30.00 Dividend /Share | 24 Jul 2026 |
| 11 Feb 2026 | board-meetings | Quarterly Results, Nine Months Results | |
| 07 Nov 2025 | board-meetings | Quarterly Results | |
| 25 Jun 2025 | dividend | Final Dividend - Rs. - 30 | 25 Jul 2025 |
| 17 May 2025 | agm | ||
| 17 May 2025 | dividend | ₹30.00 Dividend /Share | 25 Jul 2025 |
| 02 Jul 2024 | dividend | Final Dividend - Rs. - 30 | 02 Aug 2024 |
Peer Comparison
Divis Laboratories Ltd
Laurus Labs Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Zydus Lifesciences Ltd
Divis Laboratories Ltd About
Divis Laboratories is engaged in the manufacture of Active Pharmaceutical ingredients Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generics, the Company, through its custom synthesis, supports innovator pharma
Industry
Pharmaceuticals - Indian - Bulk Drugs
Founded
1990
Headquarters
CEO
Ramesh B V Nimmagadda
Employees
Contact
Website
http://www.divislabs.com
mail@divislaboratories.com; cs@divislaboratories.c
Phone
91-40-23786300/23786352/400
Location
1-72-23(P)/DIVIS/303 Divi Towe, Cyber Hills Gachibowli, Hyderabad, Telangana, 500032
Divis Laboratories Ltd Company History
| Year | History |
|---|---|
| 2019 |
|
| 2020 |
|
| 2021 |
|
| 2022 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GOLDMAN SACHS BANK EUROPE SE - ODI | block | Buy | 33108 | 6120.5 | 09 Oct 2025 |
| GOLDMAN SACHS (SINGAPORE) PTE - ODI | block | Sell | 33108 | 6120.5 | 09 Oct 2025 |
| THE MTBJ LTD.AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849 | block | Buy | 21874 | 6835 | 14 Jul 2025 |
| THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828 | block | Sell | 21874 | 6835 | 14 Jul 2025 |
| PI OPPORTUNITIES AIF V LLP | block | Buy | 80324 | 5979.65 | 06 Nov 2024 |
| PRAZIM TRADING AND INVESTMENT COMPANY PRIVATE LIMITED | block | Sell | 80324 | 5979.65 | 06 Nov 2024 |
| NORTHERN LIGHTS FUND TRUST III RONDURE NEW WORLD FUND | block | Buy | 43478 | 3637.7 | 20 Oct 2023 |
| RONDURE NEW WORLD FUND | block | Sell | 43478 | 3637.7 | 20 Oct 2023 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 209124 | 3271.4 | 14 Nov 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 209124 | 3271.4 | 14 Nov 2022 |
Frequently Asked Questions
1.What is the stock price of Divis Laboratories Ltd?
As of 07/11/2026 at 3:10 AM, Divis Laboratories Ltd shares are trading at ₹10037.50.
2.What is the market cap. of Divis Laboratories Ltd?
As of 07/11/2026, the market capitalization of Divis Laboratories Ltd is ₹2,66,264.97 crore.
3.When was Divis Laboratories Ltd founded?
Divis Laboratories Ltd was founded in 1990.
4.What are the P/E and P/B ratios of Divis Laboratories Ltd?
As of 07/11/2026, Divis Laboratories Ltd has a P/E ratio of 91.10 and a P/B ratio of 9.40.
5.How can I buy shares of Divis Laboratories Ltd?
You can buy shares of Divis Laboratories Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Divis Laboratories Ltd?
As of September,2026, promoters hold 51.88% in Divis Laboratories Ltd, while FIIs, DIIs and public shareholders hold 20.38%, 19.17% and 8.58%, respectively. The government holds 0.00%.
7.Does Divis Laboratories Ltd pay dividends?
Yes, Divis Laboratories Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹30.00 Dividend /Share per share.
8.What is the dividend yield of Divis Laboratories Ltd?
As of 07 November, 2026, the dividend yield of Divis Laboratories Ltd stands at 0.30%.
9.What are the latest financial results of Divis Laboratories Ltd?
For the financial year ended March 2025, Divis Laboratories Ltd reported revenue of ₹9,358.00 crore and a net profit of ₹2,191.00 crore.
10.What is the Stock symbol of Divis Laboratories Ltd?
DIVISLAB is the stock symbol of Divis Laboratories Ltd.
11.Who is the CEO of Divis Laboratories Ltd?
The CEO of Divis Laboratories Ltd is Ramesh B V Nimmagadda.
